Collectively, these effects lead to improved glycemic control in individuals diagnosed with type 2 diabetes
Cognitive function either improved or remained stable
This is exactly what we set out to prove when we launched Noom GLP-1 Rx : medication can accelerate progress, but behavior change sustains it
Whether it is a minor reaction at the injection site or a shift in how your skin feels, it is a manageable part of the journey for most
Drug Interactions Drugs that may increase the risk of hypoglycemia: antidiabetic agents, ACE inhibitors, angiotensin II receptor blocking agents, disopyramide, fibrates, fluoxetine, monoamine oxidase inhibitors, pentoxifylline, pramlintide, salicylates, somatostatin analog (e.g., octreotide), and sulfonamide antibiotics